2BB score and signals
4D Molecular Therapeutics, Inc.’s current 2BB score is 43 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 57 | Moderate |
| Momentum | 47 | Stable |
| Financial strength | 33 | Weak |
| Quality | 100 | Very Strong |
| Risk | 45 | Moderate |
Company facts
| Headquarters | Emeryville, California, United States |
| Founded | 2013 |
| Employees | 196 |
| 52-week range | $5.97 – $14.00 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -1.0646 | — | $2.49M |
| 2026-08-10 | — | -1.037 | — | $3.16M |
| 2026-05-07 | -1.01 | -1.0121 | $3.05M | $5.27M |
| 2026-03-18 | 0.43 | -0.7777 | $85.09M | $9.36M |
Related companies
2BBBullish & Bearish